PROMETIC’S PBI-4050: PHASE 3 PIVOTAL CLINICAL TRIAL DESIGN FOR IDIOPATHIC PULMONARY FIBROSIS (IPF) FINALIZED

January 29, 2018
Posted by: Fred Dumais
Posted In: Press Releases, Press Releases 2018
X